ATE353340T1 - Mutein von humanem thrombopoietin - Google Patents

Mutein von humanem thrombopoietin

Info

Publication number: ATE353340T1
Authority: AT; Austria
Prior art keywords: htpo; derivatives; novel; human thrombopoietin; amino acids
Prior art date: 1998-06-30

Application number

AT99929925T

Other languages

English (en)

Inventor

Joo Young Chung

Sang Myoung Ju

Hyea Kyung Ahn

Seung Wook Lim

Woo Ik Chang

Yeo Wook Koh

Ji Soo Park

Original Assignee

Dae Woong Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-06-30

Filing date

1999-06-30

Publication date

2007-02-15

1999-06-30 Application filed by Dae Woong Pharma filed Critical Dae Woong Pharma

2007-02-15 Application granted granted Critical

2007-02-15 Publication of ATE353340T1 publication Critical patent/ATE353340T1/de

Links

101000799461 Homo sapiens Thrombopoietin Proteins 0.000 title abstract 7
229940024606 amino acid Drugs 0.000 abstract 2
235000001014 amino acid Nutrition 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 2
DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 abstract 1
DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
238000011319 anticancer therapy Methods 0.000 abstract 1
229960001230 asparagine Drugs 0.000 abstract 1
235000009582 asparagine Nutrition 0.000 abstract 1
210000001185 bone marrow Anatomy 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
206010043554 thrombocytopenia Diseases 0.000 abstract 1
238000002054 transplantation Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/524—Thrombopoietin, i.e. C-MPL ligand
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Zoology (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Wood Science & Technology (AREA)
Hematology (AREA)
General Engineering & Computer Science (AREA)
Diabetes (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Amplifiers (AREA)
Fittings On The Vehicle Exterior For Carrying Loads, And Devices For Holding Or Mounting Articles (AREA)

AT99929925T 1998-06-30 1999-06-30 Mutein von humanem thrombopoietin ATE353340T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
KR19980025935		1998-06-30
KR1019990025143A KR20000006549A (ko)	1998-06-30	1999-06-29	생체내혈소판증식효능이향상된신규한트롬보포이에틴유도체

Publications (1)

Publication Number	Publication Date
ATE353340T1 true ATE353340T1 (de)	2007-02-15

Family

ID=26633859

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99929925T ATE353340T1 (de)	1998-06-30	1999-06-30	Mutein von humanem thrombopoietin

Country Status (11)

Country	Link
EP (1)	EP1092029B1 (de)
JP (2)	JP3646927B2 (de)
KR (2)	KR20000006549A (de)
CN (1)	CN1145694C (de)
AT (1)	ATE353340T1 (de)
AU (1)	AU4655899A (de)
BR (1)	BR9911686A (de)
CA (1)	CA2332126C (de)
DE (1)	DE69935071T2 (de)
ID (1)	ID27396A (de)
WO (1)	WO2000000612A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1670821A4 (de) *	2003-10-09	2006-11-29	Daewoong Co Ltd	Verfahren zur aufreinigung von humanem thrombopoietin mit hohem sialsäuregehalt
CA2658301A1 (en) *	2006-08-04	2008-02-07	Dublin City University	A method of producing recombinant biological products
EP2390261A4 (de)	2009-01-20	2012-11-14	Hanall Biopharma Co Ltd	Modifiziertes menschliches thrombopoietin-polypeptid-fragment und verfahren zu seiner herstellung
KR101594845B1 (ko) *	2014-04-29	2016-02-17	주식회사 청하	디플렉터 워터필름 수지 조성물
KR20160005968A (ko)	2014-07-08	2016-01-18	한화테크윈 주식회사	감시 카메라의 조립 구조

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2285446B (en) *	1994-01-03	1999-07-28	Genentech Inc	Thrombopoietin
EP0668352A1 (de) *	1994-02-14	1995-08-23	Kirin Brewery Company, Ltd.	Protein mit TPO-Aktivität
AU4163196A (en) *	1994-11-30	1996-06-19	Zymogenetics Inc.	Low molecular weight thrombopoietin
CA2209298C (en) *	1995-02-15	2001-12-18	Amgen Inc.	Mpl ligand analogs

1999
- 1999-06-29 KR KR1019990025143A patent/KR20000006549A/ko active Pending
- 1999-06-30 BR BR9911686-3A patent/BR9911686A/pt not_active Application Discontinuation
- 1999-06-30 WO PCT/KR1999/000347 patent/WO2000000612A1/en not_active Ceased
- 1999-06-30 KR KR1020007014775A patent/KR100331977B1/ko not_active Expired - Fee Related
- 1999-06-30 ID IDW20010195A patent/ID27396A/id unknown
- 1999-06-30 CA CA002332126A patent/CA2332126C/en not_active Expired - Fee Related
- 1999-06-30 JP JP2000557365A patent/JP3646927B2/ja not_active Expired - Fee Related
- 1999-06-30 CN CNB998077577A patent/CN1145694C/zh not_active Expired - Fee Related
- 1999-06-30 AT AT99929925T patent/ATE353340T1/de not_active IP Right Cessation
- 1999-06-30 DE DE69935071T patent/DE69935071T2/de not_active Expired - Fee Related
- 1999-06-30 AU AU46558/99A patent/AU4655899A/en not_active Abandoned
- 1999-06-30 EP EP99929925A patent/EP1092029B1/de not_active Expired - Lifetime
2004
- 2004-09-29 JP JP2004283400A patent/JP2005046156A/ja active Pending

Also Published As

Publication number	Publication date
KR20000006549A (ko)	2000-01-25
DE69935071D1 (de)	2007-03-22
CN1145694C (zh)	2004-04-14
WO2000000612A1 (en)	2000-01-06
JP2002519031A (ja)	2002-07-02
ID27396A (id)	2001-04-05
AU4655899A (en)	2000-01-17
CA2332126C (en)	2008-09-23
DE69935071T2 (de)	2007-07-26
EP1092029B1 (de)	2007-02-07
EP1092029A1 (de)	2001-04-18
KR20010078744A (ko)	2001-08-21
CA2332126A1 (en)	2000-01-06
JP3646927B2 (ja)	2005-05-11
JP2005046156A (ja)	2005-02-24
CN1306573A (zh)	2001-08-01
BR9911686A (pt)	2001-03-20
KR100331977B1 (ko)	2002-04-10

Similar Documents

Publication	Publication Date	Title
MXPA03006771A (es)	2004-05-05	Anticuerpos modificados y metodos de uso.
DE69503849D1 (de)	1998-09-10	Zusammensetzungen und Verfahren zur Anregung des Wachstums und der Differenzierung von Megakaryozyten
DE60039055D1 (de)	2008-07-10	Mittel und methoden zur beeinflussung pflanzlicher blüheigenschaften
EP1572961A4 (de)	2007-05-23	Actriib-fusionspolypeptide undverwendungen dafür
TR199802789T2 (xx)	1999-03-22	Eksendin analoglar� bunlar�n �retimi i�in y�ntemler ve bunlar� i�eren farmas�tik m�stahzarlar.
WO2001068811A3 (de)	2001-12-27	Verfahren zur in vitro-herstellung von dreidimensionalem, vitalem knorpel- oder knochengewebe und dessen verwendung als transplantationsmaterial
WO1998049300A3 (en)	1999-03-11	Truncated vegf-related proteins
ES2191511B1 (es)	2005-01-01	Derivados conjugados de eritropoyetina.
DE69631544D1 (de)	2004-03-18	Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse
ATE190352T1 (de)	2000-03-15	Dorsalgewebe beeinflussender faktor und zusammensetzungen
CA2169173A1 (en)	1995-08-17	Methods for stimulating erythropoiesis using thrombopoietin
PT851926E (pt)	2003-12-31	Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
DK11187D0 (da)	1987-01-09	Dna-sekvenser der koder for proteiner med husi-type i inhibitorers biologiske aktivitet, biotekniske fremgangsmaader til fremstilling af proteinerne o g farmaceutiske praeparater der indeholder dem
EP1401467A4 (de)	2005-07-20	Alpha-fetoprotein-peptide und ihre verwendung
DE69935071D1 (de)	2007-03-22	Mutein von humanem Thrombopoietin
DE60102147D1 (de)	2004-04-01	Anti-gefrier proteine, deren herstellung und verwendung
IL141325A0 (en)	2002-03-10	Tan-1057 derivatives
WO1997015668A3 (en)	1997-07-24	Methods and compositions comprising glut-2 and glut-2 chimeras
DE69923559D1 (de)	2005-03-10	Methoden zur inhibierung von helicobacter pylori
MY120085A (en)	2005-08-30	Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines.
EA200400174A1 (ru)	2005-06-30	Трансгенные растения, экспрессирующие кобаламинсвязывающие белки
HUP0202974A2 (hu)	2002-12-28	Fémtartalmú ribonukleotid-polipeptidek
FI954889A0 (fi)	1995-10-13	Proteiini, jolla on TPO-aktiviteetti
Asgary et al.	1998	The effect of flavonoids on the prevention of hemoglobin glycosylation
WO1998056810A3 (de)	1999-03-11	Humanes protein lus-i, seine herstellung und verwendung

Legal Events

Date	Code	Title	Description
2007-08-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties